Levetiracetam
Levetiracetam is a pharmaceutical drug with 172 clinical trials. Currently 15 active trials ongoing. Historical success rate of 88.0%.
Success Metrics
Based on 117 completed trials
Phase Distribution
Phase Distribution
19
Early Stage
42
Mid Stage
79
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
84.8%
117 of 138 finished
15.2%
21 ended early
15
trials recruiting
172
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Therapy for Children With Advanced Stage Neuroblastoma
Add on Lacosamide Versus High Dose Monotherapy
Clinical Trials (172)
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Therapy for Children With Advanced Stage Neuroblastoma
Add on Lacosamide Versus High Dose Monotherapy
Levetiracetam Three Times Daily in Epilepsy
High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
Short Versus Long-term Levetiracetam in Brain Tumors
Levetiracetam Versus Phenobarbitone for the Treatment of Neonatal Seizures in a Tertiary Care Hospital.
Treatment of Seizures in Neonate With HIE
Levetiracetam for Seizure Prevention After Brain Tumor Surgery
Population Pharmacokinetics of Antiepileptic in Pediatrics
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan Disease
Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure
Comparison of Oral Brivaracetam Versus Levetiracetam as Monotherapy in Epilepsy
Early Post-Traumatic Seizures Prevention Trial (E-PTS Trial)
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia
Efficacy Comparison Between Levetiracetam and Valproic Acid in Pediatric Patients With Status Epilepticus
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 172